Columnar Cell Variant Thyroid Gland Papillary Carcinoma
1 clinical trials · Condition
◉ Watch Columnar Cell Variant Thyroid Gland Papillary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
Track Columnar Cell Variant Thyroid Gland Papillary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.